SNCA and Parkinson disease: Parkinson’s disease (PD) is a highly prevalent neurodegenerative disease characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and intracytoplasmic accumulation of Alpha-synuclein (α-syn) in insoluble structures called Lewy bodies (LBs) [1].